Over 300 million people are affected by serious fungal infection worldwide. The situation in India is especially grim. The incidence of Candidemia in Indian ICUs is 1.2 – 34.6 patients/1000 ICU admission. It tends to infect younger and less sick patients as compared to ICU patients in developed countries. Azole resistance is high (11.8%), and overall mortality is 40%. In addition there are stories of outbreaks of Pichia anomala, Kodamaea ohmer, Candida auris, Pichia fabianii.The reasons of outbreaks include high yeast hand carriage rate (46-80%), horizontal transmission and too many patients in hospital. Invasive aspergillosis in India has certain peculiarities. The incidence is expected to be high because of below optimal hospital care practice, continuous hospital renovation work, overuse/misuse of steroids, contaminated infusion set/fluids, no HEPA filters, open window to name a few. Unlike the developed world there is increased isolation of A.flavus (up to 56%). A.flavus is more resistant to common anti fungals used. The unique features of Mucormycosis is again its high incidence 0.14/1000 population. Uncontrolled diabetes is a MAJOR RISK FACTOR. Indians love sweets. Compliance to anti-diabetic therapy is poor.
Finally there is lack of quality local data – an impediment to the development of India specific guidelines.
To discuss all these it is my privilege to invite you to the International Conference organized by Fungal Infection Study Forun (FISF) at Delhi. The Conference will be preceeded by Infectious Diseases workshop.
Professor & Head
Center for Advanced Research in Medical Mycology
& WHO Collaborating Center
Department of Medical Microbiology
Postgraduate Institute of Medical Education & Research
Last date of submission of Abstracts for poster/free paper
in Lab & Clinical Category is 15th August 2018 Download.
Download E Poster Guidelines
ABSTRACT SUBMISSION DATE IS OVER AND WILL NOT BE ACCEPTED ANYMORE